Author:
Skripnik K. K. S.,Riekes M. K.,Pezzini B. R.,Cardoso S. G.,Stulzer H. K.
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmaceutical Science,Agronomy and Crop Science,Ecology,Aquatic Science,General Medicine,Ecology, Evolution, Behavior and Systematics
Reference36 articles.
1. Takano R, Furumoto K, Shiraki K, Takata N, Hayashi Y, et al. Rate-limiting steps of oral absorption for poorly water-soluble drugs in dogs; prediction from a miniscale dissolution test and a physiologically-based computer simulation. Pharm Res. 2008;25:2334–44.
2. Krämer J, Grady LT, Gajendran J. Historical development of dissolution testing. In Pharmaceutical dissolution testing; Dressman J, Krämer J, Eds.; Taylor & Francis Group: Boca Raton, FL, 2005; 1–37.
3. Tajiri T, Morita S, Sakamoto R, Mimura H, Ozaki Y, Reppas C, et al. Developing dissolution testing methodologies for extended-release oral dosage forms with supersaturating properties. Case example: solid dispersion matrix of indomethacin. Int J Pharm. 2015;490:368–74.
4. Kulkarni P, Shahnawaz M, Zaheer Z, Dehgha MHG. Development and validation of a dissolution method for pioglitazone tablets. Dissolution Technol. 2012;19(4):36–45.
5. FDA Guidance for Industry. Guidance for industry waiver of in vivo bioavailability and bioequivalency studies for immediate-release solid dosage forms based on a biopharmaceutics classification system, 2000. US Food and Drug Administration, Center of Drug Evaluation and Research (CDER), Rockville. 2000.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献